Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer

SIMPLE SUMMARY: Several phase III randomized trials of moderate hypofractionation, including a higher proportion of high-risk prostate cancer patients treated only to the prostate, failed to demonstrate the superiority of hypofractionated regimens. There is only one randomized phase III trial, of mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Muzio, Nadia Gisella, Deantoni, Chiara Lucrezia, Brombin, Chiara, Fiorino, Claudio, Cozzarini, Cesare, Zerbetto, Flavia, Mangili, Paola, Tummineri, Roberta, Dell’Oca, Italo, Broggi, Sara, Pasetti, Marcella, Chiara, Anna, Rancoita, Paola Maria Vittoria, Del Vecchio, Antonella, Di Serio, Mariaclelia Stefania, Fodor, Andrei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508068/
https://www.ncbi.nlm.nih.gov/pubmed/34638454
http://dx.doi.org/10.3390/cancers13194970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508068/
https://www.ncbi.nlm.nih.gov/pubmed/34638454
http://dx.doi.org/10.3390/cancers13194970

Ejemplares similares